TMHA-37, a potent Nur77 modulator with cytotoxicity against HCC cell lines
Sep. 18, 2023
Researchers from Xiamen University and affiliated organizations have reported the discovery of nuclear hormone receptor NUR/77 (Nur77) modulators as potential candidates for the treatment of hepatocellular carcinoma (HCC).
